Greenwich LifeSciences Inc

Research Greenwich LifeSciences Inc (GLSI) on Bullrun: market cap USD 341.27M. Explore financials, valuation history, model signals, and stock context.

Key Metrics

• TickerGLSI
• ExchangeNASDAQ
• CountryUnited States
• SectorHealthcare
• IndustryBiotechnology
• CurrencyUSD
• Market capUSD 341.27M
• Financial periodFY2025
• Net income-USD 19.36M

Valuation Snapshot

latest market cap is USD 341.27M.

About Greenwich LifeSciences Inc

Greenwich LifeSciences, Inc., a clinical-stage biopharmaceutical company, develops novel cancer immunotherapies for breast cancer and other HER2/neu-expressing cancers in the United States. Its lead product candidate is GP2, a HER2/neu transmembrane peptide, which is in Phase III clinical trial to prevent breast cancer recurrences in patients.

Frequently asked questions

What is Greenwich LifeSciences Inc's market cap?

Greenwich LifeSciences Inc's market capitalization is USD 341.27M.

What does Greenwich LifeSciences Inc do?

Greenwich LifeSciences, Inc., a clinical-stage biopharmaceutical company, develops novel cancer immunotherapies for breast cancer and other HER2/neu-expressing cancers in the United States.